Agree...
Accumulate with ears pinned back, market cap is ridiculously low compared to others in the space.
Phase II trials in early 2018 under FDA governance is exciting.
Ann: Botanix Commences BTX 1503 Acne Patient Study, page-11
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $651.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.3¢ | 35.3¢ | $1.417M | 3.891M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 110000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 457035 | 7 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |